CURASIGHT A/S |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.98 DKK | -4.50% |
|
-0.20% | -43.77% |
| 04-16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
| 04-12 | Curasight A/S Announces Board Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 28.79M | - | - | - | - | - | |
| 49.18B | - | |||||
| 42.11B | ||||||
| 40.37B | ||||||
| 28.85B | ||||||
| 26.09B |
- Stock Market
- Equities
- CURAS Stock
- Charts Curasight A/S
- Sector Chart
